Table 1 Baseline patient characteristics

From: Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer

 

N

Percentage or range

Total patients

70

100

Male

41

59

Female

29

41

Age (median)

63 years

29–77

ECOG Performance Status 0

38

54

ECOG Performance Status 1

29

41

ECOG Performance Status 2

3

4

Disease site—bowel

58

83

Disease site—liver

58

83

Disease site—lung

25

36

Disease site—lymph nodes

24

34

Disease site—bone

1

1

Disease site—other

10

14

1 metastatic site

31

45

2 metastatic sites

26

37

3 + metastatic sites

13

18

Well differentiated tumor

7

10

Moderately differentiated tumor

45

64

Poorly differentiated tumor

9

13

Unknown degree of differentiation

9

13

Primary tumor in situ—yes

22

31

Primary tumor in situ—no

48

69

Platelets (normal range 150–400)

373

172–931 × 109/L

LDH (normal range < 450)

475

157–9335 IU/L

CEA (normal range < 5)

47

<3–16,485 IU/L

  1. CEA carcino-embryonic antigen, ECOG Eastern Cooperative Group, IU international units, LDH lactate dehydrogenase, L litre